Background During the United Kingdom Prospective Diabetes Study (UKPDS), patients with
type 2 diabetes mellitus who received intensive glucose therapy had a lower risk of …

Objective: To determine the relation between exposure to glycaemia over time and the risk
of macrovascular or microvascular complications in patients with type 2 diabetes. Design: …

The consensus algorithm for the medical management of type 2 diabetes was published in
August 2006 with the expectation that it would be updated, based on the availability of new …

ContextTreatment with diet alone, insulin, sulfonylurea, or metformin is known to improve
glycemia in patients with type 2 diabetes mellitus, but which treatment most frequently attains …

Background The efficacy of thiazolidinediones, as compared with other oral glucose-lowering
medications, in maintaining long-term glycemic control in type 2 diabetes is not known. …

Objective: To determine the relation between systolic blood pressure over time and the risk
of macrovascular or microvascular complications in patients with type 2 diabetes. Design: …

Background Data are lacking on the long-term effect on cardiovascular events of adding
sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and …

Development and progression of nephropathy in type 2 diabetes: The United Kingdom
Prospective Diabetes Study (UKPDS 64). Background The progression of nephropathy from …

The epidemic of type 2 diabetes in the latter part of the 20th and in the early 21st century,
and the recognition that achieving specific glycemic goals can substantially reduce morbidity, …

Background The cardiovascular effects of adding once-weekly treatment with exenatide to
usual care in patients with type 2 diabetes are unknown. Methods We randomly assigned …